| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 84443 |
Thyroid stimulating hormone (TSH) |
17,005 |
16,291 |
$300K |
| 80061 |
Lipid panel |
18,739 |
17,980 |
$255K |
| 80053 |
Comprehensive metabolic panel |
19,173 |
18,171 |
$213K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,627 |
3,423 |
$182K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
23,470 |
21,937 |
$166K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,984 |
4,763 |
$133K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,061 |
2,822 |
$133K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,159 |
9,764 |
$96K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,731 |
3,522 |
$91K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,855 |
3,814 |
$91K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,623 |
1,497 |
$53K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,547 |
1,422 |
$51K |
| 84153 |
|
2,657 |
2,580 |
$43K |
| 86738 |
|
3,076 |
2,861 |
$38K |
| 82607 |
|
2,657 |
2,540 |
$37K |
| 84439 |
|
4,459 |
4,249 |
$36K |
| 82274 |
|
2,817 |
2,763 |
$36K |
| 82043 |
|
6,792 |
6,541 |
$34K |
| 81001 |
|
12,735 |
12,192 |
$34K |
| 86701 |
|
3,906 |
3,708 |
$33K |
| 81000 |
|
7,728 |
7,313 |
$24K |
| 87088 |
|
2,842 |
2,663 |
$24K |
| 86328 |
|
1,162 |
1,112 |
$22K |
| 84436 |
|
3,414 |
3,286 |
$20K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,396 |
2,316 |
$19K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,525 |
2,382 |
$17K |
| 84479 |
|
3,061 |
2,950 |
$17K |
| 86592 |
|
3,665 |
3,478 |
$14K |
| 80074 |
|
277 |
247 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
4,175 |
3,903 |
$13K |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
852 |
814 |
$12K |
| 86803 |
|
536 |
498 |
$7K |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
636 |
612 |
$7K |
| 86038 |
|
570 |
549 |
$6K |
| 82570 |
|
1,037 |
969 |
$5K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
413 |
394 |
$5K |
| 82951 |
|
380 |
369 |
$5K |
| 85730 |
|
846 |
795 |
$4K |
| 85610 |
|
1,201 |
1,120 |
$4K |
| 85027 |
|
763 |
653 |
$4K |
| 85651 |
|
975 |
931 |
$3K |
| 86140 |
|
603 |
581 |
$3K |
| 84550 |
|
529 |
487 |
$2K |
| 82952 |
|
392 |
369 |
$2K |
| 82947 |
|
503 |
486 |
$2K |
| 87186 |
|
264 |
208 |
$1K |
| 87177 |
|
343 |
266 |
$1K |
| 82950 |
|
283 |
270 |
$1K |
| 85652 |
|
542 |
498 |
$1K |
| 84703 |
|
169 |
162 |
$1K |
| 84156 |
|
328 |
318 |
$829.96 |
| 84460 |
|
229 |
220 |
$821.95 |
| 84450 |
|
229 |
220 |
$802.36 |
| 86696 |
|
45 |
41 |
$726.94 |
| 83001 |
|
39 |
38 |
$680.75 |
| 86431 |
|
131 |
124 |
$625.13 |
| 82728 |
|
49 |
49 |
$485.70 |
| 80050 |
General health panel |
647 |
633 |
$432.25 |
| 83655 |
|
36 |
36 |
$411.85 |
| 81003 |
|
168 |
45 |
$382.00 |
| 86695 |
|
31 |
27 |
$364.34 |
| 82746 |
|
25 |
25 |
$343.85 |
| 86804 |
|
18 |
15 |
$263.86 |
| 87899 |
|
14 |
13 |
$247.00 |
| 86430 |
|
48 |
45 |
$224.20 |
| 84146 |
|
12 |
12 |
$218.16 |
| 82785 |
|
14 |
14 |
$205.53 |
| 84702 |
|
13 |
12 |
$183.63 |
| 86800 |
|
12 |
12 |
$152.70 |
| 83550 |
|
24 |
24 |
$149.88 |
| 83540 |
|
27 |
27 |
$130.44 |
| 82270 |
|
25 |
25 |
$72.28 |
| 86901 |
|
13 |
12 |
$36.44 |
| 86900 |
|
13 |
12 |
$36.44 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
346 |
338 |
$0.32 |